Showing results (441-450 of 2,509) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2014
Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: an emerging entity with a poor prognosisElias Jabbour, Hady Ghanem, Xuelin Huang, et al.Clinical Lymphoma, Myeloma & Leukemia|October 27, 2012
Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signalsYasser R Abou Mourad, Rahul Bhargava, Hélène Bruyère, et al.Clinical Lymphoma, Myeloma & Leukemia|May 1, 2023
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First RelapseManisha Bhutani, David M Foureau, Myra Robinson, et al.Clinical Lymphoma, Myeloma & Leukemia|May 20, 2023
POEMS Syndrome-Clinical Picture and Management. Current KnowledgeArtur Jurczyszyn, Magdalena Olszewska-Szopa, David VesoleClinical Lymphoma, Myeloma & Leukemia|July 3, 2020
High-Scatter Lymphocytes in the Blood of Erythrodermic Cutaneous T-Cell Lymphoma: Evidence for Large-Cell Transformation?Eric C Vonderheid, Jennifer Jakubowski, J Steve HouClinical Lymphoma, Myeloma & Leukemia|October 23, 2012
Autologous stem cell transplantation for multiple myeloma: identification of prognostic factorsLalit Kumar, Sunu L Cyriac, Tilak V S V G K Tejomurtula, et al.Clinical Lymphoma, Myeloma & Leukemia|September 18, 2012
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma RegistryMassimo Offidani, Laura Corvatta, Claudia Polloni, et al.Clinical Lymphoma, Myeloma & Leukemia|September 22, 2012
Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institutionKiran Turaka, J Shepard Bryan, Stephen De Souza, et al.Clinical Lymphoma, Myeloma & Leukemia|May 5, 2023
Prognostic Role of CDKN2A Deletion and p53 Expression and Association With MIPIb in Mantle Cell LymphomaFrancesco Gaudio, Michele Dicataldo, Fabrizia Di Giovanni, et al.Clinical Lymphoma, Myeloma & Leukemia|May 14, 2023
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot StudiesDilan A Patel, Fei Wan, Kathryn Trinkaus, et al.Pageof 251